APVO - Aptevo Therapeutics EPS misses by $0.10 beats on revenue November, 10 2020 04:45 PM Aptevo Therapeutics Inc. Aptevo Therapeutics (APVO): Q3 GAAP EPS of -$2.15 misses by $0.10.Revenue of $1.46M beats by $0.9M.Shares -7%.Press Release For further details see: Aptevo Therapeutics EPS misses by $0.10, beats on revenue